ERA-CRISPR/Cas12a-based, fast and specific diagnostic detection for Chlamydia pneumoniae

Yanxia Zhou1, Zijun Yan1, Shi Zhou1

  • 1The Institute of Pathogenic Biology, Hengyang Medical School, University of South China, Hengyang, China.

Insights

A new dual detection system combining enzymatic recombination amplification (ERA) and CRISPR/Cas12a rapidly and accurately diagnoses Chlamydia pneumoniae (C. pneumoniae) infections. This sensitive tool shows promise for community healthcare settings.

Area of Science:

  • Microbiology
  • Molecular Diagnostics
  • Infectious Diseases

Background:

  • Chlamydia pneumoniae (C. pneumoniae) causes significant respiratory illnesses like pneumonia.
  • Accurate and rapid diagnosis of C. pneumoniae is critical for effective treatment and public health.
  • Existing diagnostic methods may lack the speed or sensitivity required for widespread application.

Purpose of the Study:

  • To develop a novel, rapid, and sensitive dual detection platform for C. pneumoniae.
  • To integrate enzymatic recombination amplification (ERA) with CRISPR/Cas12a technology.
  • To evaluate the diagnostic performance of the Cpn-ERA-CRISPR/Cas12a dual system.

Main Methods:

  • Development of a dual system combining ERA with CRISPR/Cas12a fluorescence and lateral flow assays.
  • Testing the system's specificity against seven other common pathogens.
  • Assessing the system's sensitivity using known C. pneumoniae concentrations (10^0 copies/µL).
  • Validation using 39 clinical samples compared against quantitative PCR (qPCR).

Main Results:

  • The Cpn-ERA-CRISPR/Cas12a dual system achieved detection in 30 minutes (fluorescence) and 15 minutes (lateral flow).
  • Demonstrated high specificity with no cross-reactivity and a sensitivity of 10^0 copies/µL.
  • Achieved 100% detection rate in positive clinical samples and 0% in negative samples, matching qPCR results.

Conclusions:

  • The Cpn-ERA-CRISPR/Cas12a dual system offers a novel, rapid, and highly accurate diagnostic tool for C. pneumoniae.
  • The system's dual fluorescence and lateral flow formats provide flexibility for different clinical settings.
  • This technology holds significant potential for improving C. pneumoniae diagnostics in community healthcare.